The same sources are linked from the specific guides and provider files they inform. A provider-owned page establishes what is advertised; a medical resource supplies general context. Neither role should be stretched into a conclusion the source does not support.
Source record
Identity sources checked November 21, 2026; earlier checks are retained. Scientific sources have their own checked dates below. Earlier source records retain their original checks. Medical resources and labeling supply general context. Provider-owned pages establish advertised terms, not independently tested outcomes.
- CoreAge Rx: 4Play product informationSponsored provider; advertised formulation
- CoreAge Rx: 4Play offer and refill termsSponsored provider; advertised terms
- Hims: ED treatment optionsProvider-owned product and price page
- Ro: Erectile dysfunction treatmentProvider-owned product page
- BlueChew: Plans and GOLD formulationProvider-owned product page
- Rex MD: ED medication menuProvider-owned product and offer page
- Rex MD: Service, pharmacy and payment informationProvider-owned service page
- NIDDK: Diagnosis of erectile dysfunctionFederal patient information
- NIDDK: Symptoms and causes of erectile dysfunctionFederal patient information
- NIDDK: Treatment for erectile dysfunctionFederal patient information
- MedlinePlus: SildenafilPatient medication information
- Pfizer: Viagra prescribing and patient informationManufacturer labeling; accessed October 6, 2026
- Cialis: Manufacturer prescribing information, revised March 2026Eli Lilly approved labeling on DailyMed
- FDA: Generic Drug FactsFederal drug approval information
- FDA: Compounding questions and answersRegulatory explanation
- FDA: How to buy medicines safely from an online pharmacyFederal pharmacy-verification guidance
- HHS: Protecting data and privacy in telehealthFederal patient privacy guidance
- Henry Meds: Oral ED careProvider-owned product and subscription page
- Henry Meds: Injectable ED careProvider-owned treatment scope and starting offer
- Henry Meds: Program prices and suppliesProvider-owned program terms; page dated December 3, 2025
- Henry Meds: Refunds, returns and replacements policyProvider-owned billing and remedy policy
- Optum Perks: ED online careProvider-owned ED service and fee page
- Optum Perks: Online care overviewProvider-owned service and insurance conditions
- ZipHealth: Sildenafil pack prices and purchase optionsProvider-owned offer or policy
- ZipHealth: ED service and consultation offerProvider-owned offer or policy
- ZipHealth: General homepage and consultation statementProvider-owned offer or policy
- ZipHealth: Delivery fees and fulfillment conditionsProvider-owned offer or policy
- Push Health: ED prescription consultationProvider-owned treatment scope; updated August 12, 2026
- Push Health: Prescription requests and consultation feesProvider-owned fee and independent-practitioner explanation
- MDAnywhere: Online ED treatmentProvider-owned ED service and price information
- MDAnywhere: Treatments and service overviewProvider-owned consultation model
- FDA: Medication health fraudFederal information about unproven claims and hidden ingredients
- FDA: Sexual enhancement and energy product notificationsProduct-specific federal safety notices
- Rex MD menuProvider listing · Checked 2026-11-21
- Pfizer labelManufacturer labeling · Checked 2026-11-21
- Ro: ED product catalog and plan quantitiesProvider catalog; individual products, strengths and plan prices
- Ro: terms of use, payments and subscriptionsProvider policy; distinguish general subscription terms from Ro Body terms
- Ro Support: canceling an orderProvider support; processing orders and future shipments
- Ro Support: return and refund policyProvider support; prescription return and refund restrictions
- Ro Support: changing your prescriptionProvider support; clinical changes and follow-up
- EAU: Management of erectile dysfunctionSpecialty guideline; clinical evaluation, treatment, and limited combination evidence
- Cui et al. (2015): daily tadalafil with as-needed sildenafilPrimary clinical study; 180 patients, specific regimen, abstract reviewed via NCBI
- Ro: medication pricingProvider source; advertised plan prices and quantities
- Ro: Sparks product detailsProvider source; compounded formula, subscription pricing, and care process
- NIDDK: Diagnosis of erectile dysfunctionGovernment patient information
- MedlinePlus: TadalafilDrug information; standard tadalafil products
- DailyMed: Tadalafil prescribing information, including section 5.11Prescribing label; not evidence for the 4Play combination
- FDA: Compounding and the FDA — questions and answersGovernment guidance on compounded medications
- MedlinePlus: SildenafilDrug information; standard sildenafil products
- Ro: Daily Rise GummiesProvider source; compounded tadalafil and billing intervals
- Hims: current ED treatment catalogProvider catalog; individual named offers and starting prices
- Hims: Hard Mints formulation safety libraryProvider formulation document; includes options not confirmed in the main catalog
- Hims Support: canceling a subscriptionProvider policy; 48-hour notice and orders already processing
- Hims Support: refund policyProvider policy; no guaranteed refund after pharmacy processing
- Hims Support: when billing occursProvider policy; next order date, charge timing, and subscription intervals
- Hims Support: changing the next order dateProvider support; refill rescheduling differs from cancellation
- Hims: Hard Mints chewable ED medicinesProvider source; compounded formulations and advertised starting prices
- Hims: 3-in-1 Pill formulation and safetyProvider formulation document; sildenafil, tadalafil and vitamin B12
- Hims: Tadalafil Chews safety informationProvider formulation document; single-ingredient compounded tadalafil
- MedlinePlus: VardenafilGovernment patient drug information; standard products, not compounded equivalents
- Hims: Sex Rx + Hair Health formulationsProvider formulation document; versions with and without finasteride
- MedlinePlus: Oral minoxidilGovernment patient drug information; systemic cardiovascular warnings
- Hims: Sex Rx + Testosterone Support formulaProvider formulation document; tadalafil and supplement blend, not testosterone replacement
- NIH Office of Dietary Supplements: ZincGovernment nutrient information; intake limits and interactions
- Hims: Sex Rx + Multivitamin formulaProvider formulation document; tadalafil and listed nutrients
- Hims: Climax Control and other product formulationsProvider article; tadalafil and fluoxetine identification, not an independent comparison
- MedlinePlus: FluoxetineGovernment patient drug information; antidepressant warnings and interactions
- Hims: Sex Rx + Vitality Pro formulaProvider formulation document; tadalafil and atorvastatin
- MedlinePlus: AtorvastatinGovernment patient drug information; statin use, monitoring and adverse effects
- Hims: generic sildenafilProvider source; standard tablets and advertised starting price
- Hims: generic tadalafil tabletsProvider product page; daily and as-needed tablet options
- Hims: branded ViagraProvider product page; brand-name sildenafil and advertised price
- Hims: branded CialisProvider product page; branded tadalafil, distinct from generics
- BlueChew: platform, care process, and safety informationProvider source; current featured product and service description
- BlueChew: GOLD product and plan informationProvider source; four-ingredient compounded formulation
- FDA: Locate a state-licensed online pharmacyGovernment pharmacy verification resource
- BlueChew: GOLD published cost breakdownProvider marketing article; approximate price examples, not a checkout quote
- BlueChew: account and subscription questionsProvider policy; plan changes, one-order skips, and indefinite holds
- BlueChew: shipping and delivery questionsProvider policy; destination availability, shipping, and renewal terms
- BlueChew: returns and refunds policyProvider policy; prescription returns and 24-hour cancellation notice
- Behnia et al. (2014): intranasal oxytocin in couplesPrimary study; 29 healthy couples, different route and population from GOLD, abstract reviewed via NCBI
- Dula et al. (2001): sublingual apomorphine crossover trialPrimary randomized trial; single-ingredient apomorphine, abstract reviewed via NCBI
- BlueChew: product-specific approximate costsProvider price examples; approximate and not necessarily consistent with other offer pages
- BlueChew: combination and single-ingredient formulasProvider article; listed strengths and formulations, not independent comparative evidence
- BlueChew: product access and legacy-plan noticeProvider article; restricts certain products to existing enrolled customers; confirm account eligibility
- BlueChew: VMAX product informationProvider product page; vardenafil and tadalafil strengths
- BlueChew: named product lineupProvider article; product identification and marketing claims
- Rugiet: Ready product informationProvider source; current compounded product and consultation process
- Rugiet: Ready ingredients explainedProvider source; sildenafil, tadalafil, and apomorphine formulation
- Rugiet Support: membership options and inclusionsProvider support; plan intervals, shipping, and consultation fees
- Rugiet: terms and conditionsProvider policy; 72-hour subscription cancellation notice and refund eligibility
- Rugiet Support: canceling an order or subscriptionProvider support; member portal steps and processing restrictions
- Rugiet Support: treatment response and refundsProvider policy; refund exclusions and 24-hour order-change notice
- Pavone et al. (2004): apomorphine versus sildenafilPrimary crossover study; 34 evaluable participants, abstract reviewed via NCBI
- Rugiet: Daily Boost product informationProvider product page; tadalafil and DHEA combination
- Reiter et al. (1999): DHEA and erectile dysfunctionPrimary placebo-controlled study, 40 selected men; indexed abstract reviewed
- Morales et al. (2009): androgens and sexual functionPrimary randomized study, 86 men; indexed abstract reviewed; no significant sexual-function benefit
- Panchaprateep and Lueangarun (2020): oral minoxidil in 30 menPrimary open-label single-arm study, 24 weeks; indexed abstract reviewed, not a trial of a tadalafil combination
- Rugiet: Grower product informationProvider product page; tadalafil and oral minoxidil combination
- Goldstein 1998Primary research · Checked 2026-10-25
- Porst 2006Study · Checked 2026-10-25
- Viagra prescribing informationOfficial prescribing information · Checked 2026-10-25
- Cialis prescribing informationOfficial prescribing information · Checked 2026-10-25
- FDA: compounded drugsFDA guidance · Checked 2026-10-25
Our review method explains how sponsorship, uncertainty and access dates are handled.